Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 2, 2009, Pages 240-244

  Jiang, Ming ^a   Gou, Hong Feng ^a   Yang, Yu ^a   Cao, Dan ^a   Hou, Mei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Esophageal squamous carcinoma; Lymphangiogenesis; VEGF C; VEGF D

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D;

AGED; DRUG EFFECTS; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 63449124450     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Daly JM, Fry WA, Little AG, et al. Esophageal cancer : results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg,2000;(190(5) : 562-573.
2. Soslow RA, annenberg AJ, Rush D,et al. Cox-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer, 2000; 89(12): 2637-2645.
3. Ohno M, Nakamura T, Kunimoto Y, et al. Lymphangiogenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. Oncology Reports,2003;10(4) : 939-943.
4. VIeugel MM, Bos R, van der Groep P, et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol, 2004;57(7),746-751.
5. Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma : correlation with clinicopathologic parameters and VECF-family gene expression. Mod Pathol, 2005 ; 18(1), 143-152.
6. Franehi A, Gallo O, Massi D, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma, a morphometric study with clinical correlations. Cancer,2004 (102(5),973-978.
7. Padera TP, Kadambi A. Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science, 2002(296(5574),1883-1886.
8. Isaka N, Padera TP, Hagendoom J, et al. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res, 2004;64 (13): 4400- 4404.
9. Maula SM, Luukkaa M, Grénman R, et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res,2003;(63(8) : 1920-1926.
10. Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates re-ceptor specificity and activity of VEGF-C. EMBO J, 1997; 16(13):3898-3911.
11. Salameh A.Galvagni F.Bardelli M,et al. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation,migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood,2005;(106(10) :3423-3431.
12. Skobe M, Hawighorst T, Jackson DG,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med,2001;7(2): 192-198.
13. Stacker SA,Caesar C,Baldwin ME,et al. VEGF - D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med,20O1;7(2):186-191.
14. Kleespies A, Bruns CJ, Jauch KW, et al. Clinical significance of VEGF-A,-C and -D expression in esophageal malignancies. Onkologie,2005,28(5), 281-288.
15. Chinese source
16. vonRahdenBH, Stein HJ, Puhringer F, et al. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors ( VEGF-A, VEGF-C ) in esophageal adenocarcinoma. Cancer Res,2005,65(12), 5038-5044.
17. Noguchi T, Takeno S, Shibata T, et al. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep,2002;9 (5):995-999.